K.MoncadaS
Answer : The major players in the GLP-1 analogues market include Novo Nordisk, Eli Lilly and Company, Sanofi, AstraZeneca, Boehringer Ingelheim, Pfizer, Amgen, Roche, Zealand Pharma, Structure Therapeutics, Viking Therapeutics, Hangzhou Sciwind Biosciences, Fudan University, Eccogene, Medtronic, Merck & Co., AbbVie, Bayer AG, Teva Pharmaceutical Industries Ltd., and Boehringer Ingelheim
BPC-157 is a powerful peptide that promotes tissue regeneration by enhancing collagen production and reducing inflammation, making it effective for accelerating healing in muscles, tendons, and ligaments
Thyroid cancer We retrieved 94 cases of thyroid cancer in 28 studies enrolling 46 412 and 41 053 patients in GLP1RA and comparator groups, respectively, with a mean duration of treatment of 90.3 weeks (125 235 and 117 303 patient*years in treatment and comparator groups, respectively), without any suspected publication bias (Figure S8)